ALKS Latest Headlines

Piper Sandler Sticks to Their Buy Rating for Alkermes (ALKS)

at www.tipranks.com (Fri, 16-Jan 8:09 AM)

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Lexicon Pharmaceuticals (LXRX) and Alkermes (ALKS)

at www.tipranks.com (Fri, 16-Jan 8:01 AM)

Trump admin rolls back $2B in mental health, addiction grant cuts—report

at seekingalpha.com (Thu, 15-Jan 6:49 AM)

Alkermes’ Alixorexton Shows Statistically Significant Efficacy and Tolerability in Phase 2 Narcolepsy Type 2 Study

Market Chameleon (Wed, 12-Nov 7:58 AM)

ALKS Takes the Initiative: Alkermes Revealed as Offeror in Avadel Takeover Position Disclosure

Market Chameleon (Wed, 5-Nov 10:40 AM)

Alkermes Raises 2025 Outlook on Strong Q3 Performance: Revenue Growth and Pipeline Progress Highlight Investor Confidence

Market Chameleon (Tue, 28-Oct 9:32 AM)